Phathom Pharmaceuticals PHAT Stock Analysis 204 Loss Key Levels 20260513 Hyperfine HYPR Gains 057 Support Holds at 152 20260514 Sight Sciences SGHT Climbs 286 Resistance at 529 in Focus 20260514